Botulinum toxin for prevention of post-operative atrial fibrillation

Arnela Saljic; Malthe Emil Høtbjerg Hansen; Dobromir Dobrev

doi:10.1007/s00210-023-02402-y

Botulinum toxin for prevention of post-operative atrial fibrillation

Arnela Saljic, Malthe Emil Høtbjerg Hansen, Dobromir Dobrev^*

^*Corresponding author for this work

Physiology of circulation, kidney and lung

Research output: Contribution to journal › Editorial › Research › peer-review

4 Citations (Scopus)

Original language	English
Journal	Naunyn-Schmiedeberg's Archives of Pharmacology
Volume	396
Issue number	3
Pages (from-to)	385-388
ISSN	0028-1298
DOIs	https://doi.org/10.1007/s00210-023-02402-y
Publication status	Published - 2023

Access to Document

10.1007/s00210-023-02402-y

Cite this

@article{d8a2a22875dc49bfb0a2f15f4c99c9a7,

title = "Botulinum toxin for prevention of post-operative atrial fibrillation",

author = "Arnela Saljic and Hansen, {Malthe Emil H{\o}tbjerg} and Dobromir Dobrev",

note = "Funding Information: The authors{\textquoteright} work is supported by the National Institutes of Health (R01-HL131517, R01-HL136389, R01-HL089598, and R01-HL163277 to DD), the European Union (large-scale integrative project MAESTRIA, No. 965286 to DD), the Independent Research Fund Denmark (102900011B to AS) and the Novo Nordisk Foundation (NNF21OC0066480). ",

year = "2023",

doi = "10.1007/s00210-023-02402-y",

language = "English",

volume = "396",

pages = "385--388",

journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",

issn = "0028-1298",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Botulinum toxin for prevention of post-operative atrial fibrillation

AU - Saljic, Arnela

AU - Hansen, Malthe Emil Høtbjerg

AU - Dobrev, Dobromir

N1 - Funding Information: The authors’ work is supported by the National Institutes of Health (R01-HL131517, R01-HL136389, R01-HL089598, and R01-HL163277 to DD), the European Union (large-scale integrative project MAESTRIA, No. 965286 to DD), the Independent Research Fund Denmark (102900011B to AS) and the Novo Nordisk Foundation (NNF21OC0066480).

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85146983662&partnerID=8YFLogxK

U2 - 10.1007/s00210-023-02402-y

DO - 10.1007/s00210-023-02402-y

M3 - Editorial

C2 - 36715734

AN - SCOPUS:85146983662

SN - 0028-1298

VL - 396

SP - 385

EP - 388

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

IS - 3

ER -

Botulinum toxin for prevention of post-operative atrial fibrillation

Access to Document

Other files and links

Cite this